The Pharmaceutical Production category is one of the most critical sections in drug manufacturing, covering all major processes involved in converting raw materials into finished pharmaceutical products under strict GMP guidelines.
This section provides detailed, step-by-step guidance on key manufacturing stages such as granulation, tablet compression, coating, capsule filling, liquid manufacturing, and in-process quality control (IPC). Each topic is explained with practical industry examples to help professionals understand real-time production challenges and solutions.
Whether you are a student, production operator, or working in the pharmaceutical industry, this category will help you build strong technical knowledge, improve GMP compliance understanding, and prepare for interviews with real-life troubleshooting insights.
Pharmaceutical production directly impacts product quality, safety, and efficacy. Even a small error in the manufacturing process can lead to batch rejection or regulatory issues, making it essential to understand each step in detail.
Explore the articles below to understand each pharmaceutical manufacturing process in detail and improve your GMP knowledge step-by-step.
Introduction Black Spots in Tablets are one of the most common and visually noticeable tablet appearance defects encountered during pharmaceutical manufacturing. These defects appear as dark-colored particles, specks, or spots on the tablet surface and can significantly affect product quality, patient confidence, and regulatory compliance. This article explains the root cause of black spots in
Introduction Tablet Weight Variation is one of the most common quality defects encountered during tablet manufacturing. Maintaining consistent tablet weight is critical because it directly affects dosage accuracy, product quality, regulatory compliance, and patient safety. Excessive weight variation may indicate issues with granulation, machine settings, powder flow, or compression parameters. This article explains Tablet Weight
Introduction Double Impression in Tablets is a common visual defect observed during tablet manufacturing. This defect appears when the logo, monogram, score line, or embossed marking on a tablet is duplicated, resulting in a blurred or double-printed appearance. Although the defect may not directly affect the tablet’s potency, it significantly impacts product appearance, brand identification,
Introduction Tablet appearance is one of the most important quality attributes in pharmaceutical manufacturing. Even when a tablet meets all chemical and physical specifications, visual defects can lead to product rejection by customers and regulatory concerns. Among the common pharmaceutical tablet defects, Tablet Mottling Defect is frequently observed in both uncoated and coated tablets. This
Introduction Cracking in Tablets is a common quality defect observed during pharmaceutical tablet manufacturing. It appears as fine cracks or complete splits on the tablet surface, often reducing product quality, stability, and patient acceptance. This defect can occur during compression, coating, handling, packaging, or transportation. This article explains the causes of tablet cracking, identification methods,
Introduction Tablet Chipping Defect is one of the most common tablet manufacturing defects observed during tablet compression and handling. It occurs when small pieces break away from the edges of a tablet, resulting in an uneven appearance and reduced product quality. Chipping not only affects the visual appearance of tablets but may also indicate underlying
Introduction Tablet Picking and Sticking are among the most common tablet compression defects encountered during pharmaceutical manufacturing. These defects can affect tablet appearance, reduce product quality, increase rejection rates, and cause production delays. During the tablet compression process, powder particles may adhere to the punch face or die wall, leading to defects on the tablet
Introduction Lamination Defect in Tablets is one of the most common tablet compression defects encountered in pharmaceutical manufacturing. It occurs when a tablet separates into two or more distinct horizontal layers either during compression, ejection, packaging, transportation, or storage. Tablet lamination not only affects the physical appearance of the tablet but can also impact product
Introduction Tablet compression is one of the most critical stages in pharmaceutical manufacturing. During compression, various tablet defects can occur if formulation, granulation, equipment, or process parameters are not properly controlled. One of the most common tablet compression defects is the Capping Defect in Tablets. Capping can lead to product rejection, increased manufacturing costs, production
Introduction Tablets are the most widely used dosage form in the pharmaceutical industry due to their convenience, stability, accurate dosing, and cost-effectiveness. However, maintaining consistent tablet quality can be challenging during manufacturing. Various problems may arise during granulation, blending, compression, coating, or packaging stages, leading to tablet defects. Understanding the Common Tablet Defects in Pharmaceutical